These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 16600801
1. Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model. Lotan Y, Stanfield J, Cho LC, Sherwood JB, Abdel-Aziz KF, Chang CH, Forster K, Kabbani W, Hsieh JT, Choy H, Timmerman R. J Urol; 2006 May; 175(5):1932-6. PubMed ID: 16600801 [Abstract] [Full Text] [Related]
2. Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Walsh L, Stanfield JL, Cho LC, Chang CH, Forster K, Kabbani W, Cadeddu JA, Hsieh JT, Choy H, Timmerman R, Lotan Y. Eur Urol; 2006 Oct; 50(4):795-800; discussion 800. PubMed ID: 16632182 [Abstract] [Full Text] [Related]
3. Effects of direct injection of dehydrated ethanol on PC3 human prostate cancer cells in nude mice: preliminary study. Goya N, Koga S, Tomizawa Y, Onitsuka S, Yamaguchi Y, Toma H. Int J Urol; 2007 Aug; 14(8):760-3. PubMed ID: 17681070 [Abstract] [Full Text] [Related]
5. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Song SY, Choi W, Shin SS, Lee SW, Ahn SD, Kim JH, Je HU, Park CI, Lee JS, Choi EK. Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260 [Abstract] [Full Text] [Related]
6. Metabolic response of the CWR22 prostate tumor xenograft after 20 Gy of radiation studied by 1H spectroscopic imaging. Dyke JP, Zakian KL, Spees WM, Matei C, Chen Y, Mao X, Shungu DC, Koutcher JA. Clin Cancer Res; 2003 Oct 01; 9(12):4529-36. PubMed ID: 14555527 [Abstract] [Full Text] [Related]
7. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Fuller DB, Naitoh J, Lee C, Hardy S, Jin H. Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1588-97. PubMed ID: 18374232 [Abstract] [Full Text] [Related]
10. Impact of fraction size on lung radiation toxicity: hypofractionation may be beneficial in dose escalation of radiotherapy for lung cancers. Jin JY, Kong FM, Chetty IJ, Ajlouni M, Ryu S, Ten Haken R, Movsas B. Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):782-8. PubMed ID: 19577855 [Abstract] [Full Text] [Related]
13. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. King CR, Brooks JD, Gill H, Pawlicki T, Cotrutz C, Presti JC. Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1043-8. PubMed ID: 18755555 [Abstract] [Full Text] [Related]
14. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B. Int J Radiat Oncol Biol Phys; 2009 Jan 01; 73(1):112-8. PubMed ID: 18786780 [Abstract] [Full Text] [Related]